Drug interactions between PhosLo and Renagel
|PhosLo (calcium acetate)|
Interactions between your drugs
- PhosLo is in the following drug classes: minerals and electrolytes, phosphate binders.
- PhosLo is used to treat Hyperphosphatemia.
- Renagel is a member of the drug class phosphate binders.
- Renagel is used to treat Hyperphosphatemia of Renal Failure.
Drug and food interactions
Applies to: Renagel (sevelamer)
Sevelamer may interact with other medications if taken directly with them. As a precaution, other medications that can be affected by changes in blood levels should be administered 1 hour before or 3 hours after sevelamer. This will make it easier for your body to absorb the medication.
Therapeutic duplication warnings
Therapeutic duplication is the use of more than one medicine from the same drug category or therapeutic class to treat the same condition. This can be intentional in cases where drugs with similar actions are used together for demonstrated therapeutic benefit. It can also be unintentional in cases where a patient has been treated by more than one doctor, or had prescriptions filled at more than one pharmacy, and can have potentially adverse consequences.
The recommended maximum number of medicines in the 'phosphate binders' category to be taken concurrently is usually one. Your list includes two medicines belonging to the 'phosphate binders' category:
- calcium acetate (active ingredient in PhosLo (calcium acetate))
- sevelamer (active ingredient in Renagel (sevelamer))
Note: The benefits of taking this combination of medicines may outweigh any risks associated with therapeutic duplication. This information does not take the place of talking to your doctor. Always check with your healthcare provider to determine if any adjustments to your medications are needed.
Drug Interaction Classification
|Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.|
|Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.|
|Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.|
|No information available.|
Do not stop taking any medications without consulting your healthcare provider.